Effect of varenicline for smoking cessation in adolescents - Authors' reply.

Gray, Kevin M; Rubinstein, Mark L; Prochaska, Judith J; DuBrava, Sarah J; Holstein, Ann R; Samuels, Larry; McRae, Thomas D

Gray, Kevin M; Rubinstein, Mark L; Prochaska, Judith J; DuBrava, Sarah J; Holstein, Ann R; Samuels, Larry; McRae, Thomas D.

Afiliación

Gray KM; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC 29425, USA. Electronic address: graykm@musc.edu.
Rubinstein ML; Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA.
Prochaska JJ; Department of Medicine, Stanford University, Stanford, CA, USA.
DuBrava SJ; Pfizer, New York, NY, USA.
Holstein AR; Pfizer, New York, NY, USA.
Samuels L; Pfizer, New York, NY, USA.
McRae TD; Pfizer, New York, NY, USA.

Lancet Child Adolesc Health ; 5(2): e4, 2021 02.

Article en En | MEDLINE | ID: mdl-33484669

Asunto(s)

Cese del Hábito de Fumar; Adolescente; Humanos; Fumar; Vareniclina/uso terapéutico

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cese del Hábito de Fumar Límite: Adolescent / Humans Idioma: En Revista: Lancet Child Adolesc Health Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google